These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23899822)

  • 1. Risk of contamination of lidocaine hydrochloride and phenylephrine hydrochloride topical solution: in vivo and in vitro analyses.
    Jog M; Sachidananda R; Saeed K
    J Laryngol Otol; 2013 Aug; 127(8):799-801. PubMed ID: 23899822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-use lidocaine hydrochloride 5 per cent w/v and phenylephrine hydrochloride 0.5 per cent w/v topical spray; can it now be employed as a multi-use atomiser?
    Jog M; Zudovaite I; O'Dwyer M; Saeed K; Singh T
    J Laryngol Otol; 2020 Sep; ():1-4. PubMed ID: 32940198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An assessment for the presence of bacterial contamination of Venturi principle atomizers in a clinical setting.
    Rizzi M; Batra PS; Hall G; Citardi MJ; Lanza DC
    Am J Rhinol; 2005; 19(1):21-3. PubMed ID: 15794070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-use Venturi nasal atomizer contamination in a clinical rhinologic practice.
    Dubin MG; White DR; Melroy CT; Gergan MT; Rutala WA; Senior BA
    Am J Rhinol; 2004; 18(3):151-6. PubMed ID: 15283488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of microbial spread when using multiple-use nasal anaesthetic spray.
    Rashid M; Karagama YG
    Rhinology; 2011 Aug; 49(3):281-5. PubMed ID: 21858256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sterility of ophthalmic drugs dispensed from spray bottles.
    Kim GE; Fern KD; Perrigin JA
    Optom Vis Sci; 1997 Oct; 74(10):865-7. PubMed ID: 9383801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of possible cross-contamination with the Venturi system atomizer.
    Scianna JM; Chow JM; Hotaling A
    Am J Rhinol; 2005; 19(5):503-7. PubMed ID: 16270606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cocaine and lidocaine with phenylephrine as topical anesthetics: antimicrobial activity against common nasal pathogens.
    Aldous WK; Jensen R; Sieck BM
    Ear Nose Throat J; 1998 Jul; 77(7):554-7. PubMed ID: 9693473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparative risks of bacterial contamination between a venturi atomizer and a positive displacement atomizer.
    Wolfe TR; Hillman TA; Bossart PJ
    Am J Rhinol; 2002; 16(4):181-6; discussion 186. PubMed ID: 12222941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing cocaine solution use by promoting the use of a lidocaine-phenylephrine solution.
    Goodell JA; Gilroy G; Huntress JD
    Am J Hosp Pharm; 1988 Dec; 45(12):2510-3. PubMed ID: 3228103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of topical anesthetics without cocaine to tetracaine-adrenaline-cocaine and lidocaine infiltration during repair of lacerations: bupivacaine-norepinephrine is an effective new topical anesthetic agent.
    Smith GA; Strausbaugh SD; Harbeck-Weber C; Shields BJ; Powers JD; Hackenberg D
    Pediatrics; 1996 Mar; 97(3):301-7. PubMed ID: 8604261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial contamination of nebulizers in the home treatment of cystic fibrosis.
    Blau H; Mussaffi H; Mei Zahav M; Prais D; Livne M; Czitron BM; Cohen HA
    Child Care Health Dev; 2007 Jul; 33(4):491-5. PubMed ID: 17584406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venturi atomizers as potential sources of patient cross-infection.
    Bossart PJ; Wolfe T
    Am J Infect Control; 2003 Nov; 31(7):441-4. PubMed ID: 14639443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-phenylcaine Forte spray: innovative ways of minimising cost.
    Gungadeen A; Ramakrishnan Y; Cocks HC
    J Laryngol Otol; 2013 Nov; 127(11):1103-5. PubMed ID: 24169266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a metered-dose 8% lidocaine pump spray for patients with post-herpetic neuralgia.
    Kanai A; Kumaki C; Niki Y; Suzuki A; Tazawa T; Okamoto H
    Pain Med; 2009; 10(5):902-9. PubMed ID: 19682274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of patient cross-contamination from Venturi-Principle atomizers.
    Wolfe TR
    ORL Head Neck Nurs; 2005; 23(2):25-7. PubMed ID: 15916354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prilocaine-phenylephrine topical anesthesia for repair of mucous membrane lacerations.
    Smith GA; Strausbaugh SD; Harbeck-Weber C; Cohen DM; Shields BJ; Powers JD
    Pediatr Emerg Care; 1998 Oct; 14(5):324-8. PubMed ID: 9814396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lignocaine spray applicators are a potential source of cross-infection in the anaesthetic room.
    Williams OA; Wilcox MH; Nicol CD; Spencer RC; Reilly CS
    Anaesthesia; 1993 Jan; 48(1):61-2. PubMed ID: 8434751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of intranasal epinephrine and lidocaine spray on olfactory function tests in healthy human subjects.
    Jung YG; Ha SY; Eun YG; Kim MG
    Otolaryngol Head Neck Surg; 2011 Dec; 145(6):946-50. PubMed ID: 21846929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal lidocaine for migraine using a metered-dose spray.
    Buckley R; McCurry T; Gera J
    Headache; 2000 Jun; 40(6):498. PubMed ID: 10849050
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.